The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:733-734 February 17, 2005 Number 7
NextNext

Doctors and Drug Companies

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Blumenthal, D.
-PubMed Citation
To the Editor: Blumenthal's article (Oct. 28 issue)1 about the complex and controversial relationships between doctors and drug companies should provoke soul-searching on the part of all physicians who rationalize accepting gifts from the pharmaceutical industry. In this thoughtful and scholarly review, the author invokes the social-science literature to illustrate how even the smallest gifts can be influential.2 But he need not look so far afield. Despite the confidence expressed by many physicians that they are not influenced by the marketing efforts of pharmaceutical companies,3 an obvious indictment of their vulnerability is the annual $12 billion to $15 billion pharmaceutical . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.